Director, Mr. Frank YANG
Time of publication:     Reading times:     Typeface:【LargeMiddleSmall

Mr. Frank Yang

Mr.Frank Yang, Founding Partner & CEO, Blue Ocean Capital Group

Mr. Yang has over 20 years of experience in venture capital and private equity investment with US$ 1 billion proven track records. He led a symbolic US$ 250 million cross-border healthcare M&A which won him distinguished awards including “the Top 10 Private Equity Investments in China” and “the Best M&A Financing Award” of the year.

Before Mr. Yang founded BOCG, he served as the managing director of China Construction Bank International (“CCBI”), in charge of healthcare investment with dual currency funds. Prior to that, as head and managing director of PPF Group, a leading financial institution in Central and Eastern Europe, Mr. Yang was responsible for strategic investment in Asia and contributed to the establishment of HomeCredit China. Mr. Yang’s finance career started in 2001 when he served as a founding member and vice president of the venture capital investment arm of Xiangcai Securities, where he succeeded in raising fund and achieving a 6X return on investment.

Mr. Yang Feng is committed to the transformation of scientific research achievements of biotechnology with a focus on promoting transformation of R&D and cooperation within Guangdong-Hong Kong-Macao Greater Bay Area and between Yangtze River Delta region. Mr. Yang has been promoting corporate governance in the pharmaceutical industry in both practices and theoretical level, and had published numerous research papers in both Chinese and English and made speeches. With Mr. Yang’s initial, BOCG joined the Responsible Investment Organization supported by the United Nations (“UN PRI”), among the first batch of signing investment institutions in China to promote ESG and sustainable development.

Recent healthcare investments led by Mr. Yang including Hightide Therapeutics, Ribo Life Science, Boan Biotech, CureGenetics, Koko Life Science, Signet Therapeutics,InterHill MED and Recovery Plus etc. Mr. Yang sits on the board of HK Bio-Med Innovation Association (“HKBMIA”), Chinese Financial Association in Hong Kong(“HCFA”), PRC Committee of Hong Kong Venture Capital and Private Equity Association (“HKVCA”), and the advisory board of HKUST MBA Business School.

Mr. Yang is a PhD candidate of CUHK and holds the MBA degree from HKUST with exchange experience in Columbia University in New York and HHL Business School in Leipzig. He gained his Master’s degree in Finance from Shanghai University of Finance and Economics, and graduated from Zhongnan University of Economics and Law with a bachelor’s degree of economics.

Previous:Individual Member, Mr. Yi ZHANG
Next:Honorary President, Mr Jinyu WANG